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alter the natural history of the disease, and delay or prevent the development or
cirrhosis. Data from our unit as well as others suggests that to be the case. The
current series, many of whom have end stage disease, cannot answer that question.
This series is a large group of ill patients with end stage disease, and the authors are
to be complimented on their results with this extremely difficult high risk group.
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The Johns Hopkins University
School of Medicine
Richard Starr Ross Research Building
720 Rutland Avenue
Room 759
Baltimore
Maryland 21205-2196
United States of America
REFERENCES
1. Helzberg, J.H., Petersen, J.M. and Boyer, J.L. (1987) Improved survival with primary sclerosing
cholangitis. Gastroenterology, 92, 1869-1875
2. Cameron, J.L., Pitt, H.A., Zinner, M.J., Herlong, H.F., Kaufman, S.L., Boitnott, J.K. and
Coleman, J. (1988) Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing
cholangitis. Annals of Surgery, 207,614-622
3. Hutson, D., Russell, E., Jeffers, L., et al. (1986) Balloon dilation of biliary strictures in primary
sclerosing cholangitis through a cholodochojejuno-cutaneous fistula: a new therapeutic approach
(abstract). Gastroenterology, 90, 1470
4. Marsh, J.W., Iwatsuki, S., Makowka, L., et al. (1988) Orthotopic liver transplantation for primary
sclerosing cholangitis. Annals of Surgery, .207, 21-25
COMMON BILE DUCT STONES ERCP OR
SURGERY?
ABSTRACT
Stain, S. C., Cohen, H., Tsuishoysha, M., Donovan, A.J. (1991)
Choledocholithiasis Endoscopic sphincterotomy or common bile duct exploration.
Annals of Surgery; 213:627-634
A prospective randomized trial was conducted of preoperative endoscopic sphincter-
otomy and surgery (ES&S) or surgery alone (SA) in 52 patients with cholecystolithia-
sis and choledocholithiasis that were candidates for elective surgery. After ES&S278 HPB INTERNATIONAL
65% of patients were stone free. Eighty-eight per cent of patients with SA were stone
free after surgery (p< 0.05). Three patients in each group had residual stones at the
completion of the operation. Five of these six had more than 20 common bile duct
(CBD) stones. There was one episode ofmajor hemorrhage in a patient in each group
and no deaths. Costs were essentially equal for the individual patient with a
successful ES as compared to SA. Societal costs of a program of preoperative
endoscopic retrograde cholangiopancreatography and ES would be higher because
of the cost of screening for patients with CBD stones. These results do not support
preoperative ES as a technique for clearance of the CBD of stones on the basis of
efficacy, morbidity rate, or cost.
PAPER DISCUSSION
KEY WORDS: Endoscopic sphincterotomy, common bile duct, gallstones
This is the second prospective randomised study which has failed to demonstrate
any clear benefit of endoscopic removal of common bile duct (CBD) stones prior to
cholecystectomy (ES & S) over the conventional surgical approach. As in the larger
Leicester study morbidity and mortality was similar in patients who underwent the
seemingly less invasive endoscopic method of removal of CBD stones. The high
failure rate of endoscopic removal of CBD stones (35%), and the calculated higher
cost of preoperative screening for CBD stones were the main reasons why the
authors do not support routine endoscopic removal ofCBD stones before cholecys-
tectomy in surgically fit patients.
The apparent failure of endoscopic removal of CBD stones to confer benefit to
patients undergoing cholecystectomy is surprising and somewhat disappointing, as
this approach has several potential benefits for the patient. Firstly, the knowledge
of the number and situation of stones and possible associated bile duct anomalies
(or other pathology) may provide useful information to the surgeon in planning his
operative strategy. Secondly, successful removal of stones prior to cholecystectomy
should make the operation simpler and safer by avoiding common bile duct
exploration. Thirdly, in patients who present with jaundice and cholangitis,
cholecystectomy may be deferred until their general condition has been optimised.
Finally, in elderly patients, surgery may be delayed indefinitely, as the risk of
developing life threatening complications related to the intact gallbladder is
minimal after successful endoscopic clearance of the bile duct.
Perhaps implicit in these potential benefits of preoperative ERCP, ES and
removal of CBD stones, is the explanation why in both studies patients undergoing
the endoscopic method of removal of CBD stones did not fair better than those
who were treated with the conventional surgical approach. In patients who were
randomised to surgery alone, surgeons had the benefit of knowing exactly what the
status of the CBD pathology was prior to surgery. On the other hand, patients in
the ES & S arm of the study may not have derived the full advantage of this
approach. Most patients underwent surgery early and during the same admission. It
is conceivable that a number of patients who had a successful clearance of their bileHPB INTERNATIONAL 279
ducts could have benefited from delaying surgery; e.g. those who presented with
jaundice with or without cholangitis or the elderly patient with reversable asso-
ciated medical conditions. Unfortunately these details are not given in either of the
two randomised studies.
The high failure rate of endoscopic clearance of CBD stones in this study
requires further comment. In addition to the strict criteria used for CBD clearance
by the authors, the number of patients with innumerable stones (defined as more
than 20 stones) appeared to be considerably higher than in other reported series.
We are not given the exact number and whether they were equally distributed
between the two treatment groups, but this may offer an explanation for the lower
success rate in this study. It is also possible that a second endoscopic attempt at
removal of the stones could have improved the success rate, albeit at an increased
cost.
The comparison between the success rate of endoscopie and surgical removal of
CBD stones was somewhat artificial since all patients wre scheduled to undergo
surgery. The results can therefore be interpreted in a more positive way by
concluding that preoperative andoscopic removal of CBD stones significantly
reduced the need for CBD exploration; 12/26 (ES & S) vs 23/26 surgery alone (p <
0.003). It should also be emphasised that the incidence of retained stones after
surgery was similar in the two treatment groups and that subsequent endoscopic
removal of stones avoided further surgery in all patients.
The total incidence of retained stones after surgery in both arms of this study was
high (6/35 17%) and occurred mostly in patients with in-numerable stones. These
could have been avoided by a biliary drainage procedure but as the authors point
out, surgeons now rely increasingly on ES in this situation. Long-term follow-up in
this subgroup of patients is needed to determine the wisdom of this approach.
It is interesting to note that few septic complications occurred in this study
despite the relatively high failure rate of ES. This is contrary to the experience
reported in the Leicester study where most of the severe complications occurred in
the small number of patients in whom endoscopic clearance of CBD stones failed.
There is no apparent reason for the discrepancy between these two studies except
that patients in the Leicester study were much older, increasing their risk for sepsis.
Although the numbers were rather small in both studies, it is unlikely that a
significant difference would emerge with larger numbers, given the low morbidity
and mortality in both treatment groups. There are several other recent series which
have also reported a low morbidity and mortality for surgical removal of CBD
stones2-4. Although it appears that the endoscopic route reduces operating time and
perhaps hospital stay, it remains difficult to calculate and compare cost benefits in
different countries5.
It must be emphasised that both randomised studies only compared the outcome
of endoscopic and surgical management in patients with proven CBD stones. This
does not include the large number of patients with gallbladder stones and suspected
(but unproven) CBD stones, a problem which is frequently encountered in
practice. The detection of CBD stones with ultrasound and CT remains far from
satisfactory in patients who present with clinical and biochemical evidence of biliary
obstruction. Some patients may harbour other pathology which can mimic stones.
In this respect ERCP is superior to any other test in delineating the pathology in
biliary obstruction. Therefore, randomisation in this setting before ERCP is carried280 HPB INTERNATIONAL
out, should give a better evaluation of its diagnostic and therapeutic value in
patients who are to undergo biliary surgery.
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DOES METOCLOPRAMIDE REDUCE VARICEAL
PRESSURE?
ABSTRACT
Kleber, G., Sauerbruch, T., Fischer, G., Geigenberger, G., Paumgartner, G. (1991)
Reduction of transmural oesophageal variceal pressure by metoclopramide. Journal
of Hepatology; 12: 362-366.
In nineteen patients with portal hypertension and oesophageal varices, transmural
variceal blood pressure was determined endoscopically by direct puncture of the
varices before and after intravenous administration of 20 mg metoclopramide or
placebo. No change in pressure was observed after placebo (mean difference -1.3 __.
24.5%, N.S.), however, metociopramide reduced the pressure by 17.6 _+ 18.6% (p
0.02). Our results suggest that metociopramide may be beneficial for the
prevention of treatment of variceal haemorrhage.